BOSTON, May 3: Medical researchers announced encouraging results from clinical trials involving a new blood-based diagnostic test designed to detect multiple forms of cancer at early stages.
Scientists said the technology identifies tiny fragments of tumor DNA circulating in the bloodstream, allowing doctors to detect diseases before symptoms become severe.
Researchers believe the test could significantly improve survival rates by enabling earlier treatment interventions.
Healthcare Experts Welcome Advancement
Oncology specialists described the development as a major step toward more accessible and less invasive cancer screening.
The study reportedly involved thousands of participants across several countries and demonstrated promising accuracy rates in identifying various cancers.
Experts cautioned that additional trials and regulatory approvals will still be necessary before widespread clinical adoption.
Healthcare providers are optimistic that advanced diagnostic technologies could reduce long-term treatment costs while improving patient outcomes.